Tumour formation in multiple intestinal neoplasia (ApcMin/+) mice fed with filtered or unfiltered coffee

Seija I. Oikarinen, Iris Erlund, Marja Mutanen

Abstract


Background: The aetiology of colorectal cancer has strong dietary links, and there may be an association between coffee and colorectal cancer risk. Objective: To study the effects of filtered (low levels of kahweol/cafestol) and unfiltered (high levels of kahweol/cafestol) coffee on tumour formation in multiple intestinal neoplasia (ApcMin/+) mice. Design: ApcMin/+ mice (n=11 per group) were fed for 9 weeks with 10% w/w of these two types of coffee. Coffee was served as a dietary ingredient mixed with a semi-synthetic AIN-93G-based diet. Plasma levels of caffeine and paraxanthine were used as compliance markers. At the end of the feeding period intestinal tumour number and size were determined. The levels of β-catenin and cyclin D1, two cell-signalling proteins important to the progression of neoplasia, were also analysed in the tumour tissue. Results: Plasma caffeine and paraxanthine concentrations were 3.2±1.4 and 1.7±0.4 µmol l-1 in the filtered coffee group and 3.6±2.3 and 1.6±0.6 µmol l-1 in the unfiltered coffee group. The level of plasma xanthines was below detection in the control group. The total number of tumours was equal between the dietary groups: 29 for the control, 30 (p=0.767) for the filtered coffee and 29 (p=0.430) for the unfiltered coffee groups. The levels of β-catenin and cyclin D1 in the nuclear fraction of the tumour tissue were also the same between the groups. Conclusions: Filtered or unfiltered coffee (10% w/w) does not exert antitumorigenic activity in ApcMin/+ mice or change β-catenin and cyclin D1 signalling in the adenoma tissues. The results suggest that coffee does not change neoplasia progression in this animal model. Keywords: ApcMin/+ mice; caffeine; coffee; colon cancer; paraxanthine

Full Text: PDF

Refbacks

  • There are currently no refbacks.


Food & Nutrition Research eISSN 1654-661X
Supplements to Food & Nutrition Research eISSN 1654-661X, ISSN 1654-6628

This journal is published under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License. Responsible editor: Mikael Fogelholm.